890 results on '"Clancy, Cornelius J."'
Search Results
2. Noninvasive Testing and Surrogate Markers in Invasive Fungal Diseases
3. Genotypic diversity and unrecognized antifungal resistance among populations of Candida glabrata from positive blood cultures
4. Candida Empyema Thoracis at Two Academic Medical Centers: New Insights Into Treatment and Outcomes
5. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
6. Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19.
7. Testing Water for Legionella Prevention
8. Management of Highly Resistant Gram-Negative Infections in the Intensive Care Unit in the Era of Novel Antibiotics
9. How Clean Is the Linen at My Hospital? The Mucorales on Unclean Linen Discovery Study of Large United States Transplant and Cancer Centers
10. Exploratory Cost-Effectiveness Analysis for Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: Is Linezolid or Daptomycin Favored Over Vancomycin?
11. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis
12. Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic
13. Sequence type-258 carbapenem-resistant Klebsiella pneumoniae isolates in which ceftazidime–avibactam resistance emerged are not hypermutators
14. 1422. Surveillance for fungi in hospital environments housing high-risk hosts using culture and culture-independent methods
15. Stewardship-guided T2Candida testing shortens time to antifungal treatment and reduces antifungal usage among medical ICU patients with septic shock
16. A model program for pharmacist‐managed healthcare delivery: A tixagevimab–cilgavimab (EVUSHELD) clinic at a Veterans Affairs healthcare system
17. Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion
18. What Is New in Candida Infections? T2Candida, Antifungal Stewardship, and Candida auris
19. Testing Water for Legionella Prevention
20. Diagnosing candidemia with the T2Candida panel: an instructive case of septic shock in which blood cultures were negative
21. A model program for pharmacist‐managed healthcare delivery: A tixagevimab–cilgavimab (EVUSHELD) clinic at a Veterans Affairs healthcare system.
22. Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
23. Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2) : A Prospective, Multicenter Study of the T2Candida Panel
24. Prevention of Perioperative Infections in Organ Transplant Recipients
25. Serological Profiling of a Candida albicans Protein Microarray Reveals Permanent Host-Pathogen Interplay and Stage-Specific Responses during Candidemia
26. Ceftolozane-Tazobactam for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infections: Clinical Effectiveness and Evolution of Resistance
27. Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group
28. EDITORIAL COMMENTARY: Emergence of Candida auris: An International Call to Arms
29. Transparent Reporting at the Journal of Infectious Diseases
30. Clinical Outcomes, Drug Toxicity, and Emergence of Ceftazidime-Avibactam Resistance Among Patients Treated for Carbapenem-Resistant Enterobacteriaceae Infections
31. Stewardship-Guided T2Candida Testing Shortens Time to Antifungal Treatment and Reduces Antifungal Usage Among Medical Intensive Care Unit Patients With Septic Shock.
32. Rapid diagnosis of invasive candidiasis: ready for prime-time?
33. PCR-Based Methods for the Diagnosis of Invasive Candidiasis: Are They Ready for Use in the Clinic?
34. Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)
35. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
36. Within-Host Genotypic and Phenotypic Diversity of Contemporaneous Carbapenem-Resistant Klebsiella pneumoniae from Blood Cultures of Patients with Bacteremia
37. 1737. Xeruborbactam (QPX) Potentiates the Activity of β-Lactam (BL) Antibiotics Against a Diverse Group of Highly Drug-Resistant Enterobacterales (ENT)
38. 1837. Genotypic and Phenotypic Diversity of Contemporaneous Carbapenem Resistant Klebsiella pneumoniae from Blood Cultures of Individual Patients
39. 1736. Xeruborbactam (QPX) Potentiates the Activity of Multiple β-Lactams Against Highly Resistant Pseudomonas aeruginosa to a Greater Degree than Other β-Lactamase Inhibitors
40. 752. Decreased Echinocandin Resistance among Candida glabrata over an Eleven-Year Period at a University Hospital
41. 426. Trends in carbapenem non-susceptible (Carb-NS) Enterobacterales from hospitalized patients in the US from 2014-2020: A comparison between organisms with and without concerns for chromosomal ampC beta-lactamase hyperproduction
42. Reply to Bauer and Goff
43. T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial
44. Reply to Breazzano et al
45. Emergence of Ceftazidime-Avibactam Resistance and Restoration of Carbapenem Susceptibility in Klebsiella pneumoniae Carbapenemase-Producing K pneumoniae: A Case Report and Review of Literature
46. Water Cultures Are More Sensitive Than Swab Cultures for the Detection of Environmental Legionella
47. Testing Water for Legionella Prevention
48. Profiling of Candida albicans Gene Expression During Intra-abdominal Candidiasis Identifies Biologic Processes Involved in Pathogenesis
49. Prevention of Perioperative Infections in Organ Transplant Recipients
50. A Multicenter Comparison of Carbapenem-Nonsusceptible Enterobacterales and Pseudomonas aeruginosa Rates in the US (2016 to 2020): Facility-Reported Rates versus Rates Based on Updated Clinical Laboratory and Standards Institute Breakpoints
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.